5 reasons why you should own Ramsay Health Care Limited

Ramsay Health Care Limited (ASX:RHC) shares might look expensive but here are five reasons why this is justified.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Global private hospital operator Ramsay Health Care Limited (ASX: RHC) has provided long term shareholders with extraordinary returns. As the chart below shows, in the last 10 years Ramsay has outperformed the S&P/ASX200 (ASX:XJO) (Index:^AXJO) by nearly 600% and that doesn't even take into account the dividends it has paid during this time.

Capture

Source: Google Finance

Ramsay is one of those stocks that always appears expensive and many investors therefore find it difficult to buy. The share price has fallen from its all time high recently and this may be the opportunity investors have been waiting for.

Here are five reasons why I believe any serious long term investor should have Ramsay in their portfolio:

1. Ramsay has a global footprint. It has shown it can operate successfully overseas and now owns 212 hospitals across five countries. While other companies have struggled to export their business model overseas, Ramsay has been able to take advantage of opportunities overseas when growth opportunities have presented and this is likely to be a key driver moving forward.

2. The global demand for healthcare will continue to increase at a faster rate than ever before. The global population aged 60 or above is expected to more than triple by 2050. Longer life expectancies, new technologies and an increasing incidence of chronic diseases will increase the demand for healthcare. These strong industry fundamentals means Ramsay is well placed to take advantage of the future demands of an ageing population.

3. Ramsay has a strong history of growing earnings per share (EPS) and has a positive outlook. One look at the graph below shows how impressive earnings growth has been in the past, and although the past performance may not be an indicator of future performance, management are confident in maintaining the historical growth rate for the foreseeable future.

Capture

Source: Ramsay Company Presentation

Ramsay has recently re-affirmed its FY15 earning guidance for EPS growth of between 18-20%. At the current share price, the forecast price-to-earnings ratio is around 30 and although this is a significant premium to the broader market, this can be justified based on the company's track record and strong growth outlook.

4. The private hospital operator has a growth strategy that gives it multiple options for expansion. Ramsay has been successful so far in making acquisitions that have been beneficial to shareholders as well as improving the efficiency of its existing hospitals. The company has also recently undertaken expansions to increase the number of beds and theatre rooms to several of its hospitals that will increase revenues immediately.

5. The increasing cost of healthcare globally will become unsustainable for governments and this should see private healthcare operators carry more of the burden from the public sector. Ramsay is already aware of this and has the potential for more public-private collaborations that would see it manage more hospitals in the future.

Foolish takeaway

Although I don't think the share price is going to rocket up in the next few weeks, I believe any serious long term investors should have Ramsay in their portfolio. There have been very few opportunities to buy the company after a share price fall and the recent drop in the share price may provide an opportunity for those investors who are willing to hold on for the long term.

Motley Fool contributor Christopher Georges owns shares in Ramsay Health Care Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »